---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-24-000180"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:22:59.917640+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# USANA Q2 net sales $213M (-11% YoY), EPS $0.54 (-39%); cuts FY2024 guidance

## Summary
- Diluted EPS $0.54 vs. $0.89 in Q2 2023; net sales $213M down 11% YoY to $238M.
- Active customers fell 4% YoY to 468,000; macro pressures and fewer promotions cited.
- FY24 outlook: net sales $850-880M (prev $850-920M), EPS $2.40-2.55 (prev $2.40-3.00).
- Operating margin revised to 8.0%-8.8%; effective tax rate raised to 43%-44%.
- Cash $332M, no debt; no share repurchases in Q2; $62M authorization remaining.

## SEC filing metadata
- accession: 0000896264-24-000180
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626424000180/0000896264-24-000180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626424000180/usna-20240723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-24-000180
- JSON: https://secwatch.observer/filing/0000896264-24-000180.json
- Plain text: https://secwatch.observer/filing/0000896264-24-000180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.